GG
IMUX icon

Golden Green’s Immunic IMUX Stock Holding History

Golden Green’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,265
Closed -$369K – 77
2022
Q1 		$369K Sell
3,265
-3,226
-50% -$373K 0.3% 60
2021
Q4 		$621K Sell
6,491
-2,218
-25% -$200K 0.5% 57
2021
Q3 		$771K Buy
8,709
+595
+7% +$58.6K 0.6% 36
2021
Q2 		$995K Sell
8,114
-329
-4% -$45.5K 0.76% 29
2021
Q1 		$1.35M Buy
8,443
+1,353
+19% +$230K 1.16% 17
2020
Q4 		$1.08M Buy
+7,090
New +$1.27M 1.01% 31

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Golden Green's IMUX Position: Q2 2022 in Review

Golden Green sold out of Immunic (IMUX) in Q2 2022, closing a stake of 3,265 shares — an estimated $369K sold.

Golden Green first reported a position in IMUX in Q4 2020 and held it in 6 quarters. The position peaked at $1.35M in Q1 2021. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Golden Green reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Golden Green sold 3,265 Immunic shares in Q2 2022, an estimated $369K.
  • Golden Green first reported a position in Immunic in Q4 2020 and held it in 6 quarters.
  • Golden Green's Immunic position peaked at $1.35M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Golden Green's 13F filing for Q2 2022, filed 12 Jul 2022.